172 related articles for article (PubMed ID: 21181521)
1. Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.
Schifitto G; Deng L; Yeh TM; Evans SR; Ernst T; Zhong J; Clifford D
J Neurovirol; 2011 Feb; 17(1):17-25. PubMed ID: 21181521
[TBL] [Abstract][Full Text] [Related]
2. Selegiline and oxidative stress in HIV-associated cognitive impairment.
Schifitto G; Yiannoutsos CT; Ernst T; Navia BA; Nath A; Sacktor N; Anderson C; Marra CM; Clifford DB;
Neurology; 2009 Dec; 73(23):1975-81. PubMed ID: 19890073
[TBL] [Abstract][Full Text] [Related]
3. Preliminary differences in peripheral immune markers and brain metabolites between fatigued and non-fatigued breast cancer survivors: a pilot study.
Zick SM; Zwickey H; Wood L; Foerster B; Khabir T; Wright B; Ichesco E; Sen A; Harris RE
Brain Imaging Behav; 2014 Dec; 8(4):506-16. PubMed ID: 24222427
[TBL] [Abstract][Full Text] [Related]
4. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
Schifitto G; Navia BA; Yiannoutsos CT; Marra CM; Chang L; Ernst T; Jarvik JG; Miller EN; Singer EJ; Ellis RJ; Kolson DL; Simpson D; Nath A; Berger J; Shriver SL; Millar LL; Colquhoun D; Lenkinski R; Gonzalez RG; Lipton SA; ; ;
AIDS; 2007 Sep; 21(14):1877-86. PubMed ID: 17721095
[TBL] [Abstract][Full Text] [Related]
5. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy.
Taylor MJ; Schweinsburg BC; Alhassoon OM; Gongvatana A; Brown GG; Young-Casey C; Letendre SL; Grant I;
J Neurovirol; 2007 Apr; 13(2):150-9. PubMed ID: 17505983
[TBL] [Abstract][Full Text] [Related]
6. Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).
Vogler MA; Teppler H; Gelman R; Valentine F; Lederman MM; Pomerantz RJ; Pollard RB; Cherng DW; Gonzalez CJ; Squires KE; Frank I; Mildvan D; Mahon LF; Schock B;
J Acquir Immune Defic Syndr; 2004 May; 36(1):576-87. PubMed ID: 15097300
[TBL] [Abstract][Full Text] [Related]
7. Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.
Chang L; Ernst T; Witt MD; Ames N; Gaiefsky M; Miller E
Neuroimage; 2002 Nov; 17(3):1638-48. PubMed ID: 12414302
[TBL] [Abstract][Full Text] [Related]
8. Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals.
Letendre SL; Zheng JC; Kaul M; Yiannoutsos CT; Ellis RJ; Taylor MJ; Marquie-Beck J; Navia B;
J Neurovirol; 2011 Feb; 17(1):63-9. PubMed ID: 21246320
[TBL] [Abstract][Full Text] [Related]
9. Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests.
Keller MA; Venkatraman TN; Thomas A; Deveikis A; LoPresti C; Hayes J; Berman N; Walot I; Padilla S; Johnston-Jones J; Ernst T; Chang L
Neurology; 2004 May; 62(10):1810-7. PubMed ID: 15159483
[TBL] [Abstract][Full Text] [Related]
10. Randomized, placebo-controlled trial of Chinese herb therapy for HIV-1-infected individuals.
Weber R; Christen L; Loy M; Schaller S; Christen S; Joyce CR; Ledermann U; Ledergerber B; Cone R; Lüthy R; Cohen MR
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):56-64. PubMed ID: 10534147
[TBL] [Abstract][Full Text] [Related]
11. Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART.
Chang L; Ernst T; Witt MD; Ames N; Walot I; Jovicich J; DeSilva M; Trivedi N; Speck O; Miller EN
Antivir Ther; 2003 Feb; 8(1):17-26. PubMed ID: 12713060
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
[TBL] [Abstract][Full Text] [Related]
13. Somatic symptoms and HIV infection: relationship to depressive symptoms and indicators of HIV disease.
Perkins DO; Leserman J; Stern RA; Baum SF; Liao D; Golden RN; Evans DL
Am J Psychiatry; 1995 Dec; 152(12):1776-81. PubMed ID: 8526245
[TBL] [Abstract][Full Text] [Related]
14. Three-decade neurological and neurocognitive follow-up of HIV-1-infected patients on best-available antiretroviral therapy in Finland.
Heikinheimo T; Poutiainen E; Salonen O; Elovaara I; Ristola M
BMJ Open; 2015 Nov; 5(11):e007986. PubMed ID: 26546135
[TBL] [Abstract][Full Text] [Related]
15. Chronicity and remission of fatigue in patients with established HIV infection.
Pence BW; Barroso J; Harmon JL; Leserman J; Salahuddin N; Hammill BG
AIDS Patient Care STDS; 2009 Apr; 23(4):239-44. PubMed ID: 19281346
[TBL] [Abstract][Full Text] [Related]
16. Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.
Heseltine PN; Goodkin K; Atkinson JH; Vitiello B; Rochon J; Heaton RK; Eaton EM; Wilkie FL; Sobel E; Brown SJ; Feaster D; Schneider L; Goldschmidts WL; Stover ES
Arch Neurol; 1998 Jan; 55(1):41-51. PubMed ID: 9443710
[TBL] [Abstract][Full Text] [Related]
17. Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.
Van Dalen YW; Blokhuis C; Cohen S; Ter Stege JA; Teunissen CE; Kuhle J; Kootstra NA; Scherpbier HJ; Kuijpers TW; Reiss P; Majoie CBLM; Caan MWA; Pajkrt D
Medicine (Baltimore); 2016 Mar; 95(12):e3093. PubMed ID: 27015179
[TBL] [Abstract][Full Text] [Related]
18. HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection.
Cysique LA; Jugé L; Lennon MJ; Gates TM; Jones SP; Lovelace MD; Rae CD; Johnson TP; Nath A; Brew BJ
AIDS; 2019 Mar; 33(3):433-441. PubMed ID: 30475266
[TBL] [Abstract][Full Text] [Related]
19. Resting-state functional magnetic resonance imaging in clade C HIV: within-group association with neurocognitive function.
du Plessis L; Paul RH; Hoare J; Stein DJ; Taylor PA; Meintjes EM; Joska JA
J Neurovirol; 2017 Dec; 23(6):875-885. PubMed ID: 28971331
[TBL] [Abstract][Full Text] [Related]
20. Modafinil treatment for fatigue in HIV+ patients: a pilot study.
Rabkin JG; McElhiney MC; Rabkin R; Ferrando SJ
J Clin Psychiatry; 2004 Dec; 65(12):1688-95. PubMed ID: 15641875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
